Drug Database
AI
AidzPir (NDF 01 / AidzPir / NDF01)
✓ ApprovedUBI Pharma · Small Molecule · Small Molecule
What is AidzPir?
AidzPir is a small molecule developed by UBI Pharma. It is approved for therapeutic indications via oral (po).
Drug Profile
| Brand Names | NDF 01, AidzPir, NDF01 |
| Company | UBI Pharma |
| Drug Class | Small Molecule |
| Route | Oral (PO) |
| Status | Approved |
Sources: ClinicalTrials.gov, UBI Pharma
Therapeutic Indications
AidzPir is developed for 1 unique indication across 1 therapeutic area.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Infections and infestations | Acquired immunodeficiency syndrome | ✓ Approved |